Matches in Wikidata for { <http://www.wikidata.org/entity/Q79961133> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- Q79961133 description "article scientifique publié en 2007" @default.
- Q79961133 description "artículu científicu espublizáu en marzu de 2007" @default.
- Q79961133 description "scientific article published on 01 March 2007" @default.
- Q79961133 description "wetenschappelijk artikel" @default.
- Q79961133 description "наукова стаття, опублікована в березні 2007" @default.
- Q79961133 name "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 name "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 type Item @default.
- Q79961133 label "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 label "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 prefLabel "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 prefLabel "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 P1433 Q79961133-798ECBE3-571B-4B2B-AF31-1A0453EB3691 @default.
- Q79961133 P1476 Q79961133-D656F71E-707B-4F9C-B006-364D77D942B6 @default.
- Q79961133 P2093 Q79961133-03F71E4D-AE7E-4568-B976-A7F7D52EB221 @default.
- Q79961133 P2093 Q79961133-2BF8BDA3-1570-4758-94BF-1F7106C93D1C @default.
- Q79961133 P2093 Q79961133-342B839E-71F8-4B4C-BE94-143F004FB5A0 @default.
- Q79961133 P2093 Q79961133-591E2892-839A-4693-9C7F-604210D0C900 @default.
- Q79961133 P2093 Q79961133-66DA8A80-6254-4329-8DE5-55BF8F8D02B2 @default.
- Q79961133 P2093 Q79961133-6B434DF4-01D1-4CA4-98CB-1FEBE5F4DD32 @default.
- Q79961133 P2093 Q79961133-700EDB36-1183-4AAF-B23A-9A7653A4DE3D @default.
- Q79961133 P2093 Q79961133-7A0C6001-AE71-46E2-9E3E-6E9AD987D3AC @default.
- Q79961133 P2093 Q79961133-8B20636C-51CC-462F-B338-E8328FA99316 @default.
- Q79961133 P2093 Q79961133-ABB20268-ADBC-47FC-AD98-50D54E7DDB64 @default.
- Q79961133 P2093 Q79961133-B873C853-0301-4CD4-9595-FE2668DEF2C3 @default.
- Q79961133 P2093 Q79961133-C87EAA0F-E200-41E8-999C-6A73F84679E4 @default.
- Q79961133 P2093 Q79961133-E7670FB0-D0EF-403D-A7B9-42418DC86D35 @default.
- Q79961133 P2093 Q79961133-EFD61275-E080-4B47-8F4D-CA33C6850AA0 @default.
- Q79961133 P2093 Q79961133-F108380D-0750-44DE-89F8-61AB1B486823 @default.
- Q79961133 P2093 Q79961133-F8C4F7AD-157E-4E7E-8CF3-9D7362DFA096 @default.
- Q79961133 P2093 Q79961133-FD59AA59-5A89-4BB2-B55A-751FA20A4A10 @default.
- Q79961133 P304 Q79961133-662378BA-31AC-4D2A-A245-07C5E8520858 @default.
- Q79961133 P31 Q79961133-05F14DF5-C182-4CE0-A6BF-3FBA0D97DA62 @default.
- Q79961133 P356 Q79961133-099DBA60-4EB3-4510-987F-3360BC1D9AAA @default.
- Q79961133 P433 Q79961133-A6F53BE6-0E66-47D5-A884-3F40C06743DC @default.
- Q79961133 P478 Q79961133-F3BB36F0-F944-40D7-914A-C988DF24E283 @default.
- Q79961133 P577 Q79961133-75891606-C23A-4F94-A2B5-15CD191ED0F9 @default.
- Q79961133 P698 Q79961133-53197A2F-9177-41B7-845F-38A80466014B @default.
- Q79961133 P921 Q79961133-05CF6763-521B-4A77-BABB-6D2B1FC95CD6 @default.
- Q79961133 P921 Q79961133-BB4395ED-CB4B-4C08-9E51-BBF8E20F605C @default.
- Q79961133 P356 1078-0432.CCR-06-1892 @default.
- Q79961133 P698 17363533 @default.
- Q79961133 P1433 Q332253 @default.
- Q79961133 P1476 "Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study" @default.
- Q79961133 P2093 "Aru Narendran" @default.
- Q79961133 P2093 "Cynthia E Herzog" @default.
- Q79961133 P2093 "Eleanor G Zuhowski" @default.
- Q79961133 P2093 "Glenn Heller" @default.
- Q79961133 P2093 "Howard M Katzenstein" @default.
- Q79961133 P2093 "James A Whitlock" @default.
- Q79961133 P2093 "Jessica Boklan" @default.
- Q79961133 P2093 "Lia Gore" @default.
- Q79961133 P2093 "Luke Whitesell" @default.
- Q79961133 P2093 "Merrill J Egorin" @default.
- Q79961133 P2093 "Nichole Boucher" @default.
- Q79961133 P2093 "Richard Ho" @default.
- Q79961133 P2093 "Robert J Arceci" @default.
- Q79961133 P2093 "Rochelle Bagatell" @default.
- Q79961133 P2093 "S Percy Ivy" @default.
- Q79961133 P2093 "Stephen P Hunger" @default.
- Q79961133 P2093 "Tanya M Trippett" @default.
- Q79961133 P304 "1783-1788" @default.
- Q79961133 P31 Q13442814 @default.
- Q79961133 P356 "10.1158/1078-0432.CCR-06-1892" @default.
- Q79961133 P433 "6" @default.
- Q79961133 P478 "13" @default.
- Q79961133 P577 "2007-03-01T00:00:00Z" @default.
- Q79961133 P698 "17363533" @default.
- Q79961133 P921 Q323936 @default.
- Q79961133 P921 Q725307 @default.